Building disease-specific simulation models for patients
Total raised: $20.2M
Investors 8
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
07.01.2022 | Series A | $15M | - | marketscre... |
16.09.2019 | - | $5.2M | Serra Vent... | finsmes.co... |
Mentions in press and media 17
Date | Title | Description | Category | Author | Source |
07.01.2022 | VeriSIM Li... | Financing led by Morpheus Vent... | - | - | aithority.... |
06.01.2022 | VeriSIM Li... | VeriSIM Life, a San Francisco,... | USA | - | finsmes.co... |
06.01.2022 | VeriSIM Li... | SAN FRANCISCO, CA, VeriSIM L... | - | - | vcnewsdail... |
06.01.2022 | VeriSIM Li... | VeriSIM Life (VeriSIM) www.ver... | - | - | marketscre... |
26.07.2021 | PulmoSIM T... | After receiving orphan drug de... | - | Business W... | venturebea... |
26.07.2021 | PulmoSIM T... | All the sessions from Transfor... | - | Business W... | venturebea... |
22.03.2021 | VeriSIM Li... | SAN FRANCISCO–(BUSINESS WIRE)–... | - | Business W... | venturebea... |
22.03.2021 | VeriSIM Li... | SAN FRANCISCO--(BUSINESS WIRE)... | - | - | oaoa.com/n... |
02.03.2021 | VeriSIM Li... | SAN FRANCISCO--(BUSINESS WIRE)... | - | - | oaoa.com/n... |
25.08.2019 | VeriSIM Li... | VeriSIM Life recently announce... | - | - | pulse2.com... |
Show more